Category Archives: Ulcerative Colitis

Ulcerative colitis is a chronic idiopathic inflammatory bowel disease (IBD) of the gastrointestinal tract that affects the mucosal lining of the colon. It commonly occurs in people aged between 15 years and 30 years. Ulcerative colitis is one of the two major types of IBD along with Crohns disease Continue reading →

The Ulcerative Colitis Treatment Marketresearch report is a conscientious examination of the Ulcerative Colitis Treatment industry and offers insights such as substantial approaches, Ulcerative Colitis Treatment scope, previous information, and statistic information of the worldwide Ulcerative Colitis Treatment market. It also encloses estimated statistics that are assessed with the help of a convenient set of Ulcerative Colitis Treatment research methodologies and postulations Continue reading →

PHILADELPHIA (KYW Newsradio) One of the largest hardware stores in the nation has announced it will no longer carry carpets and rugs treated with Scotchgard. Home Depot officials say they're phasing out carpeting products treated with Scotchgard, a 3M product which contains PFAS. Continue reading →

Lawyers often get a bad rap, but we still need them in the fight for justice. Robert Bilott, on the other hand, is one of the good ones Continue reading →

If you only looked at year-to-date performance, Galapagos (NASDAQ:GLPG) would be a slam-dunk pick over Vertex Pharmaceuticals (NASDAQ:VRTX). Continue reading →

Global Ulcerative Colitis Immunology Drugs market- Report defines the vital growth factors, opportunities and market segment of top players during the forecast period from 2019 to 2025. The report Ulcerative Colitis Immunology Drugs offers a complete market outlook and development rate during the past, present, and the forecast period, with concise study, Ulcerative Colitis Immunology Drugs market effectively defines the market value, volume, price trend, and development opportunities. Continue reading →

Sydney biotech company Immutep says it will receive a $7.4 million milestone payment from GlaxoSmithKline as the global pharma giant begins a new clinical trial of an ulcerative colitis drug. GSK licensed the GSK2831781 drug from Immutep in 2010, with Immutep eligible for up to $118 million in milestone payments as well as royalties if the drug is commercialised. The trial will involve 280 patients, with results expected in early 2022 Continue reading →

One biotech companys newest director has a very familiar face. Dr. Continue reading →

If you buy something through a link on this page, we may earn a small commission. How this works. The traditional Japanese diet is a whole-foods-based diet rich in fish, seafood, and plant-based foods with minimal amounts of animal protein, added sugars, and fat Continue reading →

Amanda Brady wont deny it: She absolutely loved the way breast implants made her look. Continue reading →